Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Acute Myeloid Malignancies, AML, Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, Health outcomes research, T Cell lymphoma, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Survivorship, Human, Transplantation (Allogeneic and Autologous)
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Acute Myeloid Malignancies, AML, Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, Health outcomes research, T Cell lymphoma, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Survivorship, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Room 6B
(San Diego Convention Center)
Moderators:
Tsiporah Shore, MD, FRCPC, FACP, Weill Cornell Medical College
and
Monzr M. Al Malki, MD, City of Hope National Medical Center
Disclosures:
Shore: Bioline Rx: Consultancy. Al Malki: Incyte: Research Funding; Tscan: Consultancy; NexImmune: Consultancy, Research Funding; Tr1X: Consultancy; CareDx: Consultancy; Stemline therapeutics: Research Funding.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH